Pharmaceutical Qib 1009119-65-6 Daclatasvir Rau Kev Kho Mob Kab Mob Siab C
Khoomnpe | Daclatasvir2 HCl |
Synonyms | N,N'-[[1,1'-Biphenyl]-4,4'-diylbis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1S)-1-(1) -methylethyl)-2-oxo-2,1-ethanediyl]]] biscarbamic acid dimethyl ester hydrochloride;TIAB SA 790052 |
CAS Nr. | 1009119-65-6 |
Qhov tshwm sim | Dawb rau daj ntseg daj hmoov |
Molecular Formula | C40H50N8O6.2 (HCl) |
Molecular Luj | 811.81 ib |
Kev siv | Pharmaceutical Qib rau Kev Tshawb Fawb Lub Hom Phiaj |
Ntim | Raws li koj qhov kev thov |
Cia | Khaws nyob rau hauv nruj, lub teeb-resistant ntim nyob rau hauv ib qhov chaw txias |
Daclatasvir2 HCl Cas:1009119-65-6 | ||
Cov khoom | Txuj | Cov txiaj ntsig |
Yam ntxwv | Dawb rau daj ntseg daj hmoov | Pale-daj hmoov |
Cov ntsiab lus dej | ≦1.0% | 0.25% |
Purity | ≧99% | 99.7% |
Ib leeg impurity | ≦ 0.1% | 0.06% |
Residue ntawm ignition | ≦ 0.1% | Ua raws |
Xaus | Ua raws li cov lus qhia hauv tsev. |
Cov ntaub ntawv tuam txhab
√ Kev tswj cov txheej txheem tag nrho hauv lub Hoobkas thiab cov kws tshaj lij cov neeg ua haujlwm; √ Zoo yog ib txwm peb xav txog sab saum toj, nruj QC system; √ 11 xyoo dhau los ntawm pab pawg muag khoom; √ Kev ywj pheej R & D lab; √ Ob qhov kev kos npe mus sij hawm ntev GMP kev cob qhia; √ Cov peev txheej nplua nuj ntawm ntau lub chaw ua haujlwm tsis ua haujlwm rau qhov project customized; √ Pab neeg ua haujlwm siab ua haujlwm nrog txoj hauv kev zoo ib yam.Sau koj cov lus ntawm no thiab xa tuaj rau peb